Liu_2021_Cancer.Chemother.Pharmacol__

Reference

Title : Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine - Liu_2021_Cancer.Chemother.Pharmacol__
Author(s) : Liu D , Li X , Wang H , Dong M
Ref : Cancer Chemother Pharmacol , : , 2021
Abstract : Liu_2021_Cancer.Chemother.Pharmacol__
ESTHER : Liu_2021_Cancer.Chemother.Pharmacol__
PubMedSearch : Liu_2021_Cancer.Chemother.Pharmacol__
PubMedID: 33586000

Related information

Citations formats

Liu D, Li X, Wang H, Dong M (2021)
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine
Cancer Chemother Pharmacol :

Liu D, Li X, Wang H, Dong M (2021)
Cancer Chemother Pharmacol :